A share price of Qiagen NV [QGEN] is currently trading at $55.62, up 2.53%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The QGEN shares have gain 14.96% over the last week, with a monthly amount glided 20.90%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Qiagen NV [NYSE: QGEN] stock has seen the most recent analyst activity on January 22, 2026, when Deutsche Bank downgraded its rating to a Hold but kept the price target unchanged to $54 for it. Previously, Citigroup downgraded its rating to Neutral on December 11, 2025, and kept the price target unchanged to $50. On June 24, 2025, Barclays initiated with a Overweight rating and assigned a price target of $55 on the stock. Redburn Atlantic downgraded its rating to a Neutral. Robert W. Baird downgraded its rating to a Neutral and reduced its price target to $42 on February 19, 2025. Morgan Stanley downgraded its rating to Equal-Weight for this stock on January 06, 2025, but kept the price target unchanged to $48. In a note dated December 10, 2024, Jefferies upgraded an Buy rating on this stock and boosted its target price from $42.50 to $54.
Qiagen NV experienced fluctuations in its stock price throughout the past year between $37.59 and $57.81. Currently, Wall Street analysts expect the stock to reach $54.5 within the next 12 months. Qiagen NV [NYSE: QGEN] shares were valued at $55.62 at the most recent close of the market. An investor can expect a potential drop of -2.01% based on the average QGEN price forecast.
Analyzing the QGEN fundamentals
Trailing Twelve Months sales for Qiagen NV [NYSE:QGEN] were 2.07B which represents 6.12% growth. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at 0.23%, Pretax Profit Margin comes in at 0.24%, and Net Profit Margin reading is 0.2%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.11 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.58.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Qiagen NV [NYSE:QGEN] is 2.60. Also, the Quick Ratio is 2.30, while the Cash Ratio stands at 1.39. Considering the valuation of this stock, the price to sales ratio is 5.55, the price to book ratio is 3.14 and price to earnings (TTM) ratio is 28.50.
Transactions by insiders
Recent insider trading involved Thierry Bernard, Officer, that happened on Aug 15 ’25 when 25000.0 shares were purchased. Officer, ROLAND SACKERS completed a deal on Aug 15 ’25 to buy 31423.0 shares. Meanwhile, Officer ROLAND SACKERS bought 18577.0 shares on Aug 14 ’25.
